C07K 2317/24
Containing regions, domains or residues from different species
Official title: containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
C07K2317/24 (Containing regions, domains or residues from different species) appears on 11,246 US grants and 21,518 published applications in this corpus.
Search patents in C07K- Granted patents
- 11,246
- Published applications
- 21,518
- Assignees
- 4,214
- Inventors
- 25,725
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 9 | 0 |
| 1994 | 3 | 0 |
| 1995 | 8 | 0 |
| 1996 | 29 | 0 |
| 1997 | 62 | 0 |
| 1998 | 82 | 0 |
| 1999 | 96 | 0 |
| 2000 | 69 | 0 |
| 2001 | 60 | 25 |
| 2002 | 64 | 159 |
| 2003 | 58 | 759 |
| 2004 | 62 | 258 |
| 2005 | 54 | 291 |
| 2006 | 111 | 307 |
| 2007 | 187 | 316 |
| 2008 | 189 | 330 |
| 2009 | 183 | 471 |
| 2010 | 223 | 434 |
| 2011 | 270 | 550 |
| 2012 | 295 | 581 |
| 2013 | 384 | 671 |
| 2014 | 419 | 764 |
| 2015 | 527 | 895 |
| 2016 | 579 | 1155 |
| 2017 | 626 | 1225 |
| 2018 | 670 | 1165 |
| 2019 | 713 | 1273 |
| 2020 | 817 | 1357 |
| 2021 | 779 | 1464 |
| 2022 | 742 | 1469 |
| 2023 | 690 | 1526 |
| 2024 | 800 | 1589 |
| 2025 | 813 | 1425 |
| 2026 | 562 | 1059 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enhancement of immune response with oral immunoglobulin polypeptides6 Oct 2026US 12,752,004 B2Iogenetics, LLC
- Compositions and methods of treating lupus nephritis6 Oct 2026US 12,752,005 B2Genentech, Inc.
- Anti-galectin 3 antibodies and their use in epilepsy and related diseases6 Oct 2026US 12,752,015 B2Sunmed Therapeutic Limited
- Aggrecan binding immunoglobulins6 Oct 2026US 12,753,224 B2Ablynx N. V.
- Anti-MS4A4A antibodies and methods of use thereof6 Oct 2026US 12,753,225 B2Alector LLC
- Methods for treatment using anti-alpha4beta7 antibody8 Oct 2026US 2026/0306636 A1Takeda Pharmaceutical Company Limited
- Targeted engineered interferon and uses thereof8 Oct 2026US 2026/0308221 A1Orionis Biosciences BV
- Multi-receptor natural killer cells8 Oct 2026US 2026/0308225 A1Board of Regents, The University of Texas System
- Methods of treating inflammatory diseases8 Oct 2026US 2026/0308246 A1Boehringer Ingelheim International GmbH
- Selective reduction of cysteine residues in il-17 antibodies8 Oct 2026US 2026/0308247 A1Novartis AG
Most cited
By later US patents
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Recombinant altered antibodies and methods of making altered antibodies1,968US 5,225,539 AMedical Research Council · 1993